Project Details
Description
Posterior reversible leucoencephalopathy syndrome (PRES) is a clinico-radiological condition with various causal or precipitating factors. Clinically, it is characterised by headache, altered consciousness, visual disturbances and seizures; radiologically, by predominantly posterior, subcortical vasogenic cerebral oedema. The most frequent risk factors or triggers include hypertensive crises, immunosuppressive or immunomodulatory medications, and renal disease, and it may occur in any age group. Some case series report incidences between 2.7 % and 25 % among intensive care unit (ICU) patients, with a higher prevalence in women. Pathophysiological studies have demonstrated impaired cerebral autoregulation, cerebral hyperperfusion with hypertensive ischaemic injury, and endothelial dysfunction.
Objective
To describe the demographic, clinical and paraclinical characteristics, as well as the outcomes, of patients with PRES hospitalised at La Cardio Hospital and Hospital Universitario Mayor Méderi (Bogotá, Colombia) between January 2018 and December 2023.
Key findings
This study seeks to broaden understanding of patients with PRES and their clinico-radiological features.
Short title | PRES |
---|---|
Status | Active |
Effective start/end date | 24/10/24 → 1/06/26 |
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):
Keywords
- Reversible encephalopathy
- PRES
- Neurology
- outcomes
Mederi Institutes
- Brain, Head and Neck Institute
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.